Software & Developer Tools
AAVogen
United Statesaavogen.com
AAVogen is a startup. 1 investor tracked.
Activepre-seed
pre-seed
Stage
2018
Founded
1
Investors
About AAVogen
AAVogen is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Pre-Seed. Brouky classifies it under Software & Developer Tools. Brouky records 1 investor associated with the company.
AAVogen develops gene therapeutics for muscle wasting diseases such as inclusion body myositis, Duchenne muscular dystrophy, and heart failure, using muscle-specific AAV vectors to build muscle mass and strength.
Explore AAVogen's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.